文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

床旁血糖监测安全吗?一种符合监管要求的新风险评价方案在重症患者中的应用

Bedside Glucose Monitoring-Is it Safe? A New, Regulatory-Compliant Risk Assessment Evaluation Protocol in Critically Ill Patient Care Settings.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论在5个国际ICU的1698例重症患者中,该床旁血糖监测系统按POCT12-A3与Parkes误差网格评价,96.1%和99.3%的结果达标,研究者认为可接受用于重症患者。

这项国际多中心观察性研究在5个内科与外科ICU中,对1698例具有257种不同临床情况和复杂治疗方案的重症患者进行床旁血糖监测,并与可溯源至决定性标准的实验室参考方法比较。研究采用包含4种统计工具的临床准确性评价算法,基于临床实验室标准协会POCT12-A3标准和Parkes误差网格评价。结果显示患者病情或治疗未导致临床显著差异,分别有96.1%和99.3%的血糖结果符合上述两项标准。分层敏感度与特异度分析显示高敏感度(均值95.2%,SD±0.02)和高特异度(均值95.8%,SD±0.03);蒙特卡洛模拟显示2类和3类胰岛素剂量错误概率低,分别为2.3%(41/1815)和1.8%(32/1815);患者趋势分析显示低血糖患者特征描述一致率为99.1%(223/225)。作者认为该床旁血糖监测系统在重症患者中与中心实验室参考方法比较可接受使用。

要点

  • 在5个国际ICU的1698例重症患者中,基于POCT12-A3和Parkes误差网格,分别有96.1%和99.3%的床旁血糖结果达标,未因患者病情或治疗出现临床显著差异。
  • 蒙特卡洛模拟显示该床旁血糖监测系统的2类胰岛素剂量错误概率为2.3%(41/1815),3类为1.8%(32/1815)。
  • 患者趋势分析显示低血糖患者特征描述一致率为99.1%(223/225)。
  • 作者认为该床旁血糖监测系统在重症患者中与中心实验室参考方法比较可接受使用。

适用人群与场景

  • 5个国际内科与外科ICU收治的重症患者,共1698例,涵盖257种不同临床情况和复杂治疗方案。

研究设计与关键结果

  • 研究类型为观察性研究,在5个国际内科与外科ICU进行,纳入1698例具有257种不同临床情况和复杂治疗方案的重症患者,无干预。
  • 床旁血糖监测系统与可溯源至决定性标准的实验室参考方法比较,基于POCT12-A3和Parkes误差网格临床准确性性能标准,患者病情或治疗未导致临床显著差异,分别有96.1%和99.3%的血糖结果符合上述标准。
  • 分层敏感度与特异度分析(10 mg/dL血糖间隔,50-150 mg/dL)显示高敏感度(均值95.2%,SD±0.02)和高特异度(均值95.8%,SD±0.03)。
  • 蒙特卡洛模拟显示该床旁血糖监测系统的2类胰岛素剂量错误概率为2.3%(41/1815),3类为1.8%(32/1815)。
  • 患者趋势分析显示低血糖患者特征描述一致率为99.1%(223/225)。

证据类型、等级与局限

  • 证据类型:观察性研究。
  • 作者结论:该多组分临床准确性评价算法显示该床旁血糖监测系统在重症患者中与中心实验室参考方法比较可接受使用,该算法是全面评估重症患者全血血糖测量有效性的有效工具。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为该床旁血糖监测系统在重症患者中与中心实验室参考方法比较可接受使用。
  • 该多组分临床准确性评价算法被作者认为是全面评估重症患者全血血糖测量有效性的有效工具。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: New data have emerged from ambulatory and acute care settings about adverse patient events, including death, attributable to erroneous blood glucose meter measurements and leading to questions over their use in critically ill patients. The U.S. Food and Drug Administration published new, more stringent guidelines for glucose meter manufacturers to evaluate the performance of blood glucose meters in critically ill patient settings. The primary objective of this international, multicenter, multidisciplinary clinical study was to develop and apply a rigorous clinical accuracy assessment algorithm, using four distinct statistical tools, to evaluate the clinical accuracy of a blood glucose monitoring system in critically ill patients.

DESIGN: Observational study.

SETTING: Five international medical and surgical ICUs.

PATIENTS: All patients admitted to critical care settings in the centers.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Glucose measurements were performed on 1,698 critically ill patients with 257 different clinical conditions and complex treatment regimens. The clinical accuracy assessment algorithm comprised four statistical tools to assess the performance of the study blood glucose monitoring system compared with laboratory reference methods traceable to a definitive standard. Based on POCT12-A3, the Clinical Laboratory Standards Institute standard for hospitals about hospital glucose meter procedures and performance, and Parkes error grid clinical accuracy performance criteria, no clinically significant differences were observed due to patient condition or therapy, with 96.1% and 99.3% glucose results meeting the respective criteria. Stratified sensitivity and specificity analysis (10 mg/dL glucose intervals, 50-150 mg/dL) demonstrated high sensitivity (mean = 95.2%, SD = ± 0.02) and specificity (mean = 95. 8%, SD = ± 0.03). Monte Carlo simulation modeling of the study blood glucose monitoring system showed low probability of category 2 and category 3 insulin dosing error, category 2 = 2.3% (41/1,815) and category 3 = 1.8% (32/1,815), respectively. Patient trend analysis demonstrated 99.1% (223/225) concordance in characterizing hypoglycemic patients.

CONCLUSIONS: The multicomponent, clinical accuracy assessment algorithm demonstrated that the blood glucose monitoring system was acceptable for use in critically ill patient settings when compared to the central laboratory reference method. This clinical accuracy assessment algorithm is an effective tool for comprehensively assessing the validity of whole blood glucose measurement in critically ill patient care settings.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. DuBois JA, Slingerland RJ, Fokkert M, et al. Bedside Glucose Monitoring-Is it Safe? A New, Regulatory-Compliant Risk Assessment Evaluation Protocol in Critically Ill Patient Care Settings. Crit Care Med. 2017. PMID: 28169943. doi:10.1097/CCM.0000000000002252

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。